Optimization of Lignin-Based Biocatalyst Production from Pine Sawdust and Wheat Straw

Pine sawdust and wheat straw are abundant lignocellulosic wastes that have been recently converted into bioethanol under a biochemical platform scheme whose main waste is lignin. Lignin can be transformed into a wide variety of high added-value products, including its functionalization as a catalyst. A key step in the synthesis of a lignin-based catalyst is the sulfonation reaction, whose operating conditions, namely, H2SO4 to lignin ratio (mL/g), temperature and time, have been arbitrarily chosen. In this contribution, an optimization methodology (i.e., Box-Behnken) is applied in order to found the operating conditions during the sulfonation reaction that maximizes the total acid sites density of lignin-based catalysts from pine sawdust and wheat straw. The optimization results show that the time in sulfonation reactions can be significantly reduced, compared to those previously reported, without affecting the performance of both catalysts in esterification reactions. These results could be further considered for energy and costs reduction purposes during the conceptual design engineering of the sulfonation reaction

Serum interleukin-8 reflects tumor burden and treatment response across malignancies of multiple tissue origins

Purpose: Interleukin-8 (IL8) is a chemokine produced by malignant cells of multiple cancer types. It exerts various functions in shaping protumoral vascularization and inflammation/immunity. We evaluated sequential levels of serum IL8 in preclinical tumor models and in patients to assess its ability to estimate tumor burden. Experimental Design:IL8levels were monitored by sandwich ELISAsin cultured tumor cells supernatants, tumor-xenografted mice serum, and in samples from 126 patients with cancer. We correlated IL8 serum levels with baseline tumor burden and with treatment-induced changes in tumor burden, as well as with prognosis. Results: IL8 concentrations correlated with the number of IL8-producing tumor cells in culture. In xenografted neoplasms, IL8 serum levels rapidly dropped after surgical excision, indicating an accurate correlation with tumor burden. In patients with melanoma (n ¼ 16), renal cell carcinoma (RCC; n ¼ 23), non–small cell lung cancer (NSCLC; n ¼ 21), or hepatocellular carcinoma (HCC; n ¼ 30), serum IL8 concentrations correlated with tumor burden and stage, survival (melanoma, n ¼ 16; RCC, n ¼ 23; HCC, n ¼ 33), and objective responses to therapy, including those to BRAF inhibitors (melanoma, n ¼ 16) and immunomodulatory monoclonal antibodies (melanoma, n ¼ 8). IL8 concentrations in urine (n ¼ 18) were mainly elevated in tumors with direct contact with the urinary tract. Conclusions: IL8 levels correlate with tumor burden in preclinical models and in patients with cancer. IL8 is a potentially useful biomarker to monitor changes in tumor burden following anticancer therapy, and has prognostic significance